Clinical Trial Update: Tolerance, Safety, Efficacy, and Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel for Platinum-resistant Recurrent Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating paclitaxel delivered via pressurized intraperitoneal aerosol chemotherapy for platinum-resistant recurrent ovarian canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Ovarian Neoplasms, Peritoneal Neoplasms | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING